Reduced cytomegalovirus reactivation and viremia without increasing GVHD after URD-PBSCT: A prospective study using targeted ATG dosing strategy.

Cancer Pathog Ther · 2026 · PMC12856173 · PMID 41624481

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

historical cohort: 78.9% [95% CI: 62.3%–88.6%], HR = 0.465 [95% CI: 0.146–1.482], P = 0.195; [ Figure 3 D]) were improved in the targeted-dosing ATG cohort; however, these improvements did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.